A comprehensive view of Skin Disorders/Dermatology. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Health Canada approves Bristol Myers Squibb’s Sotyktu deucravacitinib tablets to treat severe plaque psoriasis in adults; Psoriasis is a chronic inflammatory condition that affects nearly a million Canadians
Published: November 28, 2022 by Canada Newswire
Australian sunscreen brand Sunny Skin expands into the US with pop-up store in Showfields in Miami Beach, Florida; brand makes mineral face sunscreens for rosacea, eczema, hyperpigmentation and sensitive skins
Published: November 21, 2022 by AB Digital
CeraVe establishes fund at Howard University, a historically Black university with a Department of Dermatology, to help faculty further expertise, obtain certification and build infrastructure needed to conduct clinical trials with focus on skin of color
Published: November 16, 2022 by PR Newswire
Regeneron and Sanofi announce European Medicines Agency recommends approval of Dupixent injectable in the EU to treat adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy; final decision expected in coming months
Published: November 11, 2022 by dpa-AFX International Compact
Heyday acquires acne treatment brand ZitSticka; acquisition grows Heyday's investment in the personal care space, will provide a leading position in the high-growth category of acne patches
Published: November 09, 2022 by PR Newswire

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count